Skip to content

Tc17-driven antibody-independent mucosal immunity is critical for protection against extracellular bacterial pneumonia

Aug 2026 · bioRxiv · 0 citations
Biology

TL;DR

It is shown that protective immunity conferred by mucosal mRNA vaccines (but not parenteral) require neither serum IgG nor airway secretory IgA, but instead depends on a previously unrecognized lung-resident CD8⁺IL-17⁺ T-cells (Tc17) that rapidly recruits neutrophils/macrophages to eliminate bacteria.

View source

Similar papers

Review Open access Sep 2026

Trained immunity-based mucosal immunotherapies for preventing respiratory infections: a translational, evidence-graded appraisal of platforms, populations, and the protection–immunopathology balance

Conventional respiratory vaccines protect through antigen-specific immunity, leaving broad gaps against antigenically diverse and emerging pathogens and inducing little protection at the airway surface itself. Trained immunity, the durable epigenetic and metabolic reprogramming of innate immune cells and their bone mar...

Yanhong Lyu, Feng-Jun Zhang, Qiong Zhao · 0 citations
Open access Aug 2026

An adenovirus-based multiantigen vaccine protects against tuberculosis by coordinating adaptive immunity and curbing immunosuppressive mechanisms

The identification of a multi-antigen vaccine candidate, Ad-8CPR2, as the most immunogenic construct, which incorporates M. tuberculosis antigenic proteins with strong immunogenicity and functional properties, which are fused with peptide segments capable of augmenting antigen-specific immune responses.

Li-Qun Wei, Peng Wang, Ying Li et al. · 0 citations
Open access Sep 2026

ESAT-6-derived lipopeptide-based mucosal vaccine elicits distinct humoral immune responses concomitant with a reduction in mycobacterium infection

These findings revealed that incorporating HKCC significantly increased cellular responses and mucosal IgA and systemic IgG titres in pre- and post-exposure models, respectively, and correlated with reduced mycobacterial burden in the lungs, spleens, and livers and with improved lung pathology.

Shanika Werellagama, Nancy Gupta, Jie Li et al. · 0 citations
Open access Oct 2026

Long-term immunoprophylaxis by TLR9 ligand mediates macrophage-ILC cross-talk against respiratory viral infection

Rapid development of host immunity is critical during the emergence of viral outbreaks when vaccines are not yet available. Here, we demonstrate that CpG oligodeoxynucleotide-schizophyllan complex (K3-SPG) induces antigen-independent, long-term protection against lethal respiratory virus infection. A single intranasal...

Asuka Joy Tobuse, K. Kobiyama, Jun Tsuchida et al. · 0 citations
Open access Sep 2026

Synthetic adjuvants to potentiate the immune response against rAg85B by nasal route

Respiratory infections remain a relevant global health concern nowadays. The rapid dissemination and high mutational ratio of some pathogens, amid human demographic drivers, increases their pandemic potential. On the other hand, some bacterial infections have re-emerged with new resistant variants, supporting the need...

Rong Chen, Chang-Zan Tan, Wen Li et al. · 0 citations
#protein folding Open access Sep 2026

An intranasal bivalent vaccine induces antigen-specific humoral and Th1/Th17 cellular immunity and protects young and aged mice against MRSA and Pseudomonas aeruginosa skin and soft tissue infections

ABSTRACT Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA) are ESKAPE pathogens that are responsible for severe skin and soft tissue infections (SSTIs), particularly in the elderly and those with immunocompromising conditions. Rising rates of methicillin-resistant S. aureus (MRSA) and carbapenem-resistant PA h...

Suhrid Maiti, T. Lu, Zackary Dietz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.